ZyVersa Therapeutics, Inc.

ZVSA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$1,531$3,138$5,902$329
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$185$215$460$483
Total Curr. Assets$1,716$3,353$6,363$812
Property Plant & Equip (Net)$0$15$116$28
Goodwill$0$0$11,895$0
Intangibles$18,648$18,648$100,086$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$236$98$47$287
Total NC Assets$18,884$18,761$112,144$314
Other Assets$0$0$0$0
Total Assets$20,599$22,114$118,506$1,126
Liabilities
Payables$9,337$8,432$6,026$2,000
Short-Term Debt$0$9$109$9,152
Tax Payable$0$0$107$0
Deferred Revenue$0$0$0$17
Other Curr. Liab.$1,894$1,755$1,947$2,458
Total Curr. Liab.$11,231$10,195$8,188$13,626
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$852$845$10,324$0
Other NC Liab.$0$0$0$0
Total NC Liab.$852$845$10,324$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$12,083$11,040$18,512$13,626
Equity
Pref Stock$0$0$331$331
Common Stock$0$0$1$0
Retained Earnings-$112,633-$103,219-$4,921-$52,897
AOCI$0$0$0$0
Other Equity$121,149$114,293$104,583$40,065
Total Equity$8,516$11,075$99,994-$12,500
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$20,599$22,114$118,506$1,126
Net Debt-$1,531-$3,129-$5,793$8,823